Pt 141 Bremelanotide Injection

Name: Pt 141 Bremelanotide Injection
Brand: BV VAN DONGEN BOB
Price: 1500.0 INR
Availability: InStock

Price 1500.0 INR/ Box

Get a Price/Quote

MOQ : 25 Boxes

Pt 141 Bremelanotide Injection Specification

Dosage Form
Lyophilized powder

Pacakaging (Quantity Per Box)
Typically one vial per box

Indication
Intended for laboratory and research study only

Life Span
Refer to package/date of manufacture

Packaging Type
Sealed Glass Vial

Salt Composition
Bremelanotide

Drug Type
Peptide

Ingredients
Bremelanotide injection, also known by its original research code PT-141, is a prescription medication approved by the FDA under the brand name Vyleesi . It is used specifically to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

Physical Form
Injection (vial)

Function
Peptide research, Not for human consumption

Recommended For
Research Use Only

Dosage
10 mg per vial

Dosage Guidelines
As per research protocol

Suitable For
Researchers, Laboratory Use

Quantity
10 mg

Storage Instructions
Store under cool, dry conditions; refrigerate if required

Purity
99% Purity

Appearance
Clear, sterile vial

Application
Preclinical/clinical research studies, in vitro/vivo testing

Color
White lyophilized powder

About Pt 141 Bremelanotide Injection

Bremelanotide injection, also known by its original research code PT-141, is a prescription medication approved by the FDA under the brand name Vyleesi. It is used specifically to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

High Purity for Reliable Research

PT-141 Bremelanotide Injection offers 99% purity, ensuring experimental consistency and reliability. Its sterile presentation and lyophilized powder form minimize contamination risks, supporting robust results in preclinical and clinical research environments.

Applications and Use Cases

Designed strictly for research use, this peptide is ideal for laboratory studies, including in vitro and in vivo applications. It allows researchers to study bremelanotide's properties, mechanisms, and effects in protocols related to peptide function and sexual behavior disorders.

FAQ's of Pt 141 Bremelanotide Injection:

Q: How should PT-141 Bremelanotide Injection be stored before use?

A: PT-141 Bremelanotide Injection should be kept under cool, dry conditions and may require refrigeration according to packaging instructions. Proper storage preserves the product's integrity for research purposes.

Q: What is the recommended method for using this product in research?

A: The dosage and method of use should be determined according to your research protocol. The vial contains 10 mg of bremelanotide as a lyophilized powder, suitable for reconstitution and administration in preclinical or clinical research settings.

Q: When is this product appropriate for researchers to use?

A: PT-141 Bremelanotide Injection is recommended for use only in laboratory and research settings, specifically in preclinical and clinical studies investigating peptide roles, not for human administration.

Q: Where should this peptide product be applied in a laboratory setting?

A: PT-141 Bremelanotide is suitable for a range of applications including biological assays, pharmacological studies, and mechanism research involving in vitro or in vivo methods.

Q: What is the benefit of choosing this injection for research purposes?

A: With 99% purity and sterile, sealed packaging, this product provides the precision and safety aligned with demanding scientific research, ensuring reproducible and reliable data.

Q: How is PT-141 supplied and what is the typical packaging?

A: PT-141 Bremelanotide is provided as a lyophilized powder in a sealed, clear glass vial, typically one vial per box, maintaining sterility and stability for laboratory use.